偏頭痛治療市場：按治療藥物、給藥途徑、地區 - 規模、份額、前景和機會分析，2022-2028 年

偏頭痛是一種神經系統症狀，通常被描述為頭部某一部位出現強烈的抽動性或抽動性疼痛。 疼痛通常是單側的、搏動性的，並且通常隨著運動而加重。 偏頭痛是一種頭痛，往往會引起其他體徵和症狀，例如噁心和視力模糊。 目前還沒有治愈偏頭痛的方法，但藥物可以預防、停止或使症狀惡化。

市場動態：

偏頭痛患病率的增加、對安全有效治療的需求不斷增加、人們對偏頭痛及其治療的認識不斷提高以及全球研究和開發的不斷增加將是全球偏頭痛增長的主要因素。頭痛藥物市場。 例如，偏頭痛是一種嚴重且常見的神經系統疾病，嚴重影響生活質量。 2020 年，偏頭痛被世界衛生組織列為因殘疾損失年數最多的神經系統疾病。

2022年2月，Biohaven Pharmaceutical Holding Co., Ltd.和輝瑞宣布，歐洲藥品管理局（EMA）人用藥品委員會通過了對rimegepant的肯定意見。 該藥物以 75 mg 的 rimegepant 劑量用於成人有或無先兆偏頭痛的急性治療，以及每月偏頭痛發作 4 次或以上的成人持續性偏頭痛的預防性治療。（以口服溶解片劑形式銷售） ).

這項研究的主要特點

• 本報告對全球偏頭痛藥物市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2028 年）的市場規模和復合年增長率 (CAGR%) 增長情況。
• 它還揭示了不同細分市場的潛在創收機會，並為市場勾勒出一個有吸引力的投資建議矩陣。
• 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
• 它根據以下參數介紹了全球偏頭痛治療市場的主要參與者，包括公司亮點、產品組合、主要亮點、財務業績和戰略。
• 本研究涵蓋的主要公司包括輝瑞公司、諾華國際公司、默克公司、葛蘭素史克公司、禮來公司、阿斯利康公司、安進公司、艾爾建公司、博士倫保健公司., 和 Teva Pharmaceutical Industries Ltd. 等。
• 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
• 本研究報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球偏頭痛治療市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 按治療劑分類的市場概況
  • 按給藥途徑劃分的市場概況
  • 市場概況：按地區
• 連貫機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

• 市場動態
  • 全球偏頭痛患病率不斷上升
  • 藥物副作用和未確診病例增加
  • 對安全有效治療的需求不斷增長
• 影響分析
• 主要亮點
• 監管情景
• 產品發布/批准
• 害蟲分析
• 對 PORTER 的分析
• 合併/收購場景

第 4 章全球偏頭痛藥物市場 - 冠狀病毒 (COVID-19) 大流行的影響

• COVID-19 的流行病學特徵
• 供應方和需求方分析
• 經濟影響

第 5 章全球偏頭痛藥物市場：按藥物分類，2017-2028

• 止痛藥
• 預防醫學

第 6 章全球偏頭痛藥物市場：按給藥途徑，2017-2028

• 口腔/鼻腔
• 注射

第 7 章全球偏頭痛治療市場：按地區劃分，2017-2028

• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東和非洲
• 世界其他地方

第八章競爭格局

• Pfizer Inc.
• Novartis International AG
• Merck & Co. Inc.
• GlaxoSmithKline PLC
• Eli Lilly and Company
• AstraZeneca PLC
• Amgen Inc.
• Allergan Inc.
• Bausch Health Companies Inc.
• Teva Pharmaceutical Industries Ltd.

第 9 章

• 調查方法
• 關於出版商

Migraine is a neurological disorder often described as intense pulsing or throbbing pain in one area of the head. The pain is often unilateral and pulsating in nature, which can often be worsened by physical activity. Migraines are a type of headache that tend to cause other signs and symptoms, too, such as nausea and vision problems. There's no cure for migraines yet, but medicines can help prevent or stop them, or keep signs and symptoms from getting worse.

Market Dynamics:

Increase in prevalence of migraine, increase in demand for safe and effective treatment, increase in awareness about migraine and its treatment options, and rise in research and development across the world are major factors expected to propel the growth of the global migraine therapeutic market during the forecast period. For instance, migraine is a serious and common neurological condition with a serious impact on quality of life. In 2020, migraine has been ranked by WHO as the most prevalent neurological condition causing the highest loss of years due to disability.

In February 2022, Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. reported that the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) adopted a positive opinion for Rimegepant. It is recommended as the 75 mg dose of Rimegepant (available as an orally dissolving tablet) for marketing authorization for both the acute treatment of migraine with or without aura in adults and the preventive treatment of episodic migraine in adults who have at least four migraine attacks per month.

Key features of the study:

• This report provides in-depth analysis of the global migraine therapeutic market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global migraine therapeutic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Pfizer Inc., Novartis International AG, Merck & Co. Inc., GlaxoSmithKline PLC, Eli Lilly and Company, AstraZeneca PLC, Amgen Inc., Allergan Inc., Bausch Health Companies Inc., and Teva Pharmaceutical Industries Ltd., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global migraine therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global migraine therapeutic market.

Detailed Segmentation:

• Global Migraine Therapeutic Market, By Therapeutics:
  • Pain-relieving Medications
  • Preventive Medications
• Global Migraine Therapeutic Market, By Route of Administration:
  • Oral and Nasal
  • Injection
• Global Migraine Therapeutic Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • Pfizer Inc.
  • Novartis International AG
  • Merck & Co. Inc.
  • GlaxoSmithKline PLC
  • Eli Lilly and Company
  • AstraZeneca PLC
  • Amgen Inc.
  • Allergan Inc.
  • Bausch Health Companies Inc.
  • Teva Pharmaceutical Industries Ltd.

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Therapeutics
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increase in prevalence of migraine around the world
  • Adverse effects of drugs and increasing undiagnosed cases
  • Increase in demand for safe and effective treatment
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Migraine Therapeutic Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Migraine Therapeutic Market, By Therapeutics, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Pain-relieving Medications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Preventive Medications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Migraine Therapeutic Market, By Route of Administration, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Oral and Nasal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Injection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Migraine Therapeutic Market, By Geography, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

8. Competitive Landscape

• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis International AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co. Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Amgen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Allergan Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bausch Health Companies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us